Polypharmacy correlates with increased risk for hip fracture in the elderly: A population-based study

Medicine

Volumn 89, Issue 5, 2010, Pages 295-299

  Lai, Shih Wei ^a   Liao, Kuan Fu ^b   Liao, Chien Chang ^c   Muo, Chih Hsin ^c   Liu, Chiu Shong ^a   Sung, Fung Chang ^c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NON PRESCRIPTION DRUG;

AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HIGH RISK POPULATION; HIP FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYPHARMACY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TAIWAN; AGE; DRUG THERAPY; FALLING; HEALTH SURVEY; HIP FRACTURES; PREVALENCE; PROCEDURES; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ACCIDENTAL FALLS; AGE FACTORS; AGED; AGED, 80 AND OVER; DRUG THERAPY; FEMALE; HIP FRACTURES; HUMANS; MALE; POLYPHARMACY; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SEX FACTORS; TAIWAN;

EID: 77957270714     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181f15efc     Document Type: Article

References (30)

1. Agostini JV, Han L, Tinetti ME. The relationship between number of medications and weight loss or impaired balance in older adults. J Am Geriatr Soc. 2004;52:1719-1723.
2. American Geriatrics Society Panel on Falls Prevention OSP. Guideline for the prevention of falls in older persons. J Am Geriatr Soc. 2001;49:664-672.
3. Ballentine NH. Polypharmacy in the elderly: maximizing benefit, minimizing harm. Crit Care Nurs Q. 2008;31:40-45.
4. Baranzini F, Poloni N, Diurni M, Ceccon F, Colombo D, Colli C, Ferrari G, Callegari C. [Polypharmacy and psychotropic drugs as risk factors for falls in long-term care setting for elderly patients in Lombardy]. Recenti Prog Med. 2009;100:9-16.
5. Boonen S, Dequeker J, Pelemans W. Risk factors for falls as a cause of hip fracture in the elderly. Acta Clin Belg. 1993;48:190-194.
6. Braithwaite RS, Col NF, Wong JB. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc. 2003;51:364-370.
7. Chan DC, Hao YT, Wu SC. Characteristics of outpatient prescriptions for frail Taiwanese elders with long-term care needs. Pharmacoepidemiol Drug Saf. 2009;18:327-334.
8. Corsinovi L, Bo M, Ricauda Aimonino N, Marinello R, Gariglio F, Marchetto C, Gastaldi L, Fissore L, Zanocchi M, Molaschi M. Predictors of falls and hospitalization outcomes in elderly patients admitted to an acute geriatric unit. Arch Gerontol Geriatr. 2009;49: 142-145.
9. Cranwell-Bruce LA. The connection between patient falls and medication. Medsurg Nurs. 2008;17:189-191.
10. Delafuente JC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol. 2003;48:133-143.
11. Fife D, Barancik JI. Northeastern Ohio Trauma Study III: incidence of fractures. Ann Emerg Med. 1985;14:244-248.
12. French DD, Campbell R, Spehar A, Cunningham F, Foulis P. Outpatient medications and hip fractures in the US: a national veterans study. Drugs Aging. 2005;22:877-885.
13. Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005;17:123-132.
14. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345-351.
15. Hanlon JT, Cutson T, Ruby CM. Drug-related falls in the older adult. Top Geriatr Rehabil. 1996;11:38-54.
16. Hayes WC, Myers ER, Robinovitch SN, Van Den Kroonenberg A, Courtney AC, McMahon TA. Etiology and prevention of age-related hip fractures. Bone. 1996;18:77S-86S.
17. Jacqmin-Gadda H, Fourrier A, Commenges D, Dartigues JF. Risk factors for fractures in the elderly. Epidemiology. 1998;9: 417-423.
18. Jorgensen T, Johansson S, Kennerfalk A, Wallander MA, Svardsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother. 2001;35:1004-1009.
19. Kannus P, Parkkari J, Sievanen H, Heinonen A, Vuori I, Jarvinen M. Epidemiology of hip fractures. Bone. 1996;18:57S-63S.
20. Karas S Jr. The potential for drug interactions. Ann Emerg Med. 1981;10:627-630.
21. Lau EM, Woo J, Leung PC, Swaminthan R. Low bone mineral density, grip strength and skinfold thickness are important risk factors for hip fracture in Hong Kong Chinese. Osteoporos Int. 1993;3:66-70.
22. Lauritzen JB. Hip fractures: incidence, risk factors, energy absorption, and prevention. Bone. 1996;18:65SY75S
23. Ministry of the Interior, Taiwan. Resident Population by 5-Year, 10-Year Age Group. EAccessed 2009 June^ http://sowf.moi.gov.tw/stat/month/m1-06.xls.
24. Moayyeri A, Soltani A, Larijani B, Naghavi M, Alaeddini F, Abolhassani F. Epidemiology of hip fracture in Iran: results from the Iranian Multicenter Study on Accident Injuries. Osteoporos Int. 2006;17:1252-1257.
25. Nurmi-Luthje I, Kaukonen JP, Luthje P, Naboulsi H, Tanninen S, Kataja M, Kallio ML, Leppilampi M. Use of benzodiazepines and benzodiazepine-related drugs among 223 patients with an acute hip fracture in Finland: comparison of benzodiazepine findings in medical records and laboratory assays. Drugs Aging. 2006; 23:27-37.
26. Robbins AS, Rubenstein LZ, Josephson KR, Schulman BL, Osterweil D, Fine G. Predictors of falls among elderly people: results of two population-based studies. Arch Intern Med. 1989;149: 1628-1633.
27. Shao CJ, Hsieh YH, Tsai CH, Lai KA. A nationwide seven-year trend of hip fractures in the elderly population of Taiwan. Bone. 2009;44: 125-129.
28. Stewart RB, Cooper JW. Polypharmacy in the aged. Practical solutions. Drugs Aging. 1994;4:449-461.
29. Tinetti ME. Clinical practice. Preventing falls in elderly persons. N Engl J Med. 2003;348:42-49.
30. Ziere G, Dieleman JP, Hofman A, Pols HA, van der Cammen TJ, Stricker BH. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol. 2006;61:218-223.